Cargando…
The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16(INK4a)
BACKGROUND: CDKN2A/p16(INK4a )is frequently altered in human cancers and it is the most important melanoma susceptibility gene identified to date. p16(INK4a )inhibits pRb phosphorylation and induces cell cycle arrest, which is considered its main tumour suppressor function. Nevertheless, additional...
Autores principales: | Becker, Therese M, Haferkamp, Sebastian, Dijkstra, Menno K, Scurr, Lyndee L, Frausto, Monika, Diefenbach, Eve, Scolyer, Richard A, Reisman, David N, Mann, Graham J, Kefford, Richard F, Rizos, Helen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644676/ https://www.ncbi.nlm.nih.gov/pubmed/19149898 http://dx.doi.org/10.1186/1476-4598-8-4 |
Ejemplares similares
-
p16(INK4a)-induced senescence is disabled by melanoma-associated mutations
por: Haferkamp, Sebastian, et al.
Publicado: (2008) -
The relative contributions of the p53 and pRb pathways in
oncogene-induced melanocyte senescence
por: Haferkamp, Sebastian, et al.
Publicado: (2009) -
BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1’s Interaction with Specific Cellular Pathways
por: Shaykevich, Aaron, et al.
Publicado: (2023) -
Mechanism of BRG1 silencing in primary cancers
por: Marquez, Stefanie B., et al.
Publicado: (2016) -
The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer
por: Romero, Octavio A, et al.
Publicado: (2012)